- Home
- SST vs CASI Comparison
SST vs CASI Comparison
Compare SST & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SST
- CASI
- Stock Information
- Founded
- SST 2013
- CASI 1991
- Country
- SST United States
- CASI China
- Employees
- SST N/A
- CASI N/A
- Industry
- SST Diversified Commercial Services
- CASI Biotechnology: Pharmaceutical Preparations
- Sector
- SST Consumer Discretionary
- CASI Health Care
- Exchange
- SST Nasdaq
- CASI Nasdaq
- Market Cap
- SST 23.3M
- CASI 20.5M
- IPO Year
- SST N/A
- CASI 1996
- Fundamental
- Price
- SST $5.74
- CASI $1.76
- Analyst Decision
- SST Strong Buy
- CASI Strong Buy
- Analyst Count
- SST 1
- CASI 1
- Target Price
- SST $10.00
- CASI $4.00
- AVG Volume (30 Days)
- SST 59.2K
- CASI 3.4M
- Earning Date
- SST 08-07-2025
- CASI 08-19-2025
- Dividend Yield
- SST N/A
- CASI N/A
- EPS Growth
- SST N/A
- CASI N/A
- EPS
- SST N/A
- CASI N/A
- Revenue
- SST $317,055,000.00
- CASI $31,368,000.00
- Revenue This Year
- SST N/A
- CASI N/A
- Revenue Next Year
- SST $8.39
- CASI N/A
- P/E Ratio
- SST N/A
- CASI N/A
- Revenue Growth
- SST N/A
- CASI 8.39
- 52 Week Low
- SST $2.90
- CASI $1.09
- 52 Week High
- SST $15.30
- CASI $7.67
- Technical
- Relative Strength Index (RSI)
- SST 44.70
- CASI 53.72
- Support Level
- SST $4.95
- CASI $1.46
- Resistance Level
- SST $6.31
- CASI $1.72
- Average True Range (ATR)
- SST 0.70
- CASI 0.25
- MACD
- SST -0.18
- CASI 0.03
- Stochastic Oscillator
- SST 23.06
- CASI 29.32
About SST System1 Inc.
System1 Inc develops technology and data science to operate a responsive acquisition marketing platform. It serves customers in the areas of health and wellness, automotive, finance, travel, and entertainment. The company's segment includes Owned and Operated Advertising (O&O); and Partner Network. It generates maximum revenue from the Owned and Operated Advertising (O&O) segment. Geographically, it operates in United States and Other countries.
About CASI CASI Pharmaceuticals Inc.
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.